<form id="jhhvn"></form><form id="jhhvn"><th id="jhhvn"><track id="jhhvn"></track></th></form>

    <address id="jhhvn"><address id="jhhvn"><nobr id="jhhvn"></nobr></address></address>
      <address id="jhhvn"></address>

      www.mebliok.com 提示:

      本信息僅供醫學專業人士參考,如果您是醫學專業人士,請點擊確定后進入。 如果不是,請點擊取消。

      取消 確定

      3SBio Group has always been committed to solving the problem of
      clinical drug use for patients, constantly conquering the challenges
      of the disease, using high-quality drugs to improve the quality of
      life of patients, and working hard for the benefit of human health.

      Cooperation partners

      • Exclusive license for the commercialization of GLP-1 products in China

      • Exclusive license to develop and commercialize programmed therapeutic cells in Greater China

      • Exclusive license for the distribution and promotion of insulin products

      • Collaboration for clinical development and commercialization of MCM1 in China

      • Exclusive partnership to commercialize liposomal products utilizing NanoX? in Mainland China


      • Priority for potential licensing or development of two ophthalmic-related disease products

      • Exclusive right to develop and commercialize Remitch in China

      • Partnership focused on the development and commercialization of novel bi- and multi-specific antibodies in the field of immuno-oncology

      • Collaboration for clinical development and commercialization of multiple biosimilars in China

      • Potential licensing priorities for four inner ear disease related research products

      • Investment to research and develop early stage cancer drugs

      九九99热久久精品在线22,不卡岛国aV一区二区,91在线视频观看免费,国产swag视频在线,欧美 日韩 国产 自拍在线视频,国产在线观看主播自慰,少女萝莉映画视频,手机国产网红主播视频福利